These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 33304284)

  • 61. Manifestations and mechanisms of central nervous system damage caused by SARS-CoV-2.
    Yang F; Zhao H; Liu H; Wu X; Li Y
    Brain Res Bull; 2021 Dec; 177():155-163. PubMed ID: 34571039
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.
    Xu B; Li G; Guo J; Ikezoe T; Kasirajan K; Zhao S; Dalman RL
    J Vasc Surg; 2021 Nov; 74(5):1740-1751. PubMed ID: 33600934
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences.
    Lahiri D; Mondal R; Deb S; Bandyopadhyay D; Shome G; Sarkar S; Biswas SC
    Diabetes Metab Syndr; 2020; 14(5):1053-1060. PubMed ID: 32640417
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anti-inflammatory drugs and the renin-angiotensin-aldosterone system: Current knowledge and potential effects on early SARS-CoV-2 infection.
    Cabbab ILN; Manalo RVM
    Virus Res; 2021 Jan; 291():198190. PubMed ID: 33039544
    [TBL] [Abstract][Full Text] [Related]  

  • 65. TGF-β1 Inhibition of ACE2 Mediated by miRNA Uncovers Novel Mechanism of SARS-CoV-2 Pathogenesis.
    Hejenkowska ED; Mitash N; Donovan JE; Chandra A; Bertrand C; De Santi C; Greene CM; Mu F; Swiatecka-Urban A
    J Innate Immun; 2023; 15(1):629-646. PubMed ID: 37579743
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.
    Offringa A; Montijn R; Singh S; Paul M; Pinto YM; Pinto-Sietsma SJ
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):317-325. PubMed ID: 32464637
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
    Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
    Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Ambrocio-Ortiz E; Pérez-Rubio G; Del Ángel-Pablo AD; Buendía-Roldán I; Chávez-Galán L; Hernández-Zenteno RJ; Ramírez-Venegas A; Rojas-Serrano J; Mejía M; Pérez-Padilla R; Guadarrama-Pérez C; Falfán-Valencia R
    Pharmaceuticals (Basel); 2021 Aug; 14(8):. PubMed ID: 34451902
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future.
    Zhang J; Wang M; Ding W; Wan J
    Life Sci; 2020 Sep; 257():118142. PubMed ID: 32712300
    [TBL] [Abstract][Full Text] [Related]  

  • 70. SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
    Kettunen P; Lesnikova A; Räsänen N; Ojha R; Palmunen L; Laakso M; Lehtonen Š; Kuusisto J; Pietiläinen O; Saber SH; Joensuu M; Vapalahti OP; Koistinaho J; Rolova T; Balistreri G
    J Virol; 2023 Apr; 97(4):e0014423. PubMed ID: 37039676
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
    Cheng H; Wang Y; Wang GQ
    J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19.
    Sackin H
    Med Hypotheses; 2021 Jul; 152():110609. PubMed ID: 34048987
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients.
    Ermis U; Rust MI; Bungenberg J; Costa A; Dreher M; Balfanz P; Marx G; Wiesmann M; Reetz K; Tauber SC; Schulz JB
    Neurol Res Pract; 2021 Mar; 3(1):17. PubMed ID: 33712089
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Multi-Data Integration Towards a Global Understanding of the Neurological Impact of Human Brain Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Mesmoudi S; Lapina C; Rodic M; Peschanski D
    Front Integr Neurosci; 2022; 16():756604. PubMed ID: 35910337
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors and Coronavirus Disease 2019 (COVID-19).
    Albashir AAD
    South Med J; 2021 Jan; 114(1):51-56. PubMed ID: 33398362
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity.
    Gonçalves J; Santos CD; Fresco P; Fernandez-Llimos F
    Rev Port Cardiol; 2023 Apr; 42(4):373-383. PubMed ID: 36893838
    [TBL] [Abstract][Full Text] [Related]  

  • 77. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome.
    Devaux CA; Rolain JM; Raoult D
    J Microbiol Immunol Infect; 2020 Jun; 53(3):425-435. PubMed ID: 32414646
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2).
    To KF; Lo AW
    J Pathol; 2004 Jul; 203(3):740-3. PubMed ID: 15221932
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) on the nervous system. What can we expect from SARS -CoV-2?
    Monroy-Gómez J; Torres-Fernández O
    Biomedica; 2020 Oct; 40(Supl. 2):173-179. PubMed ID: 33152201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.